We are live on ! Find out more
UOC

UBS O'Connor Portfolio holdings

AUM $3.76B
1-Year Est. Return 62.41%
This Fund
S&P 500
This Quarter Est. Return
+9.23%
1 Year Est. Return
+62.41%
3 Year Est. Return
+179.84%
5 Year Est. Return
+371.69%
10 Year Est. Return
+1,534.25%
AUM
$4.22B
AUM Growth
-$1.2B
Cap. Flow
-$1.32B
Cap. Flow %
-31.23%
Top 10 Hldgs %
40.53%
Holding
893
New
143
Increased
129
Reduced
82
Closed
273
Avg Time Held Equity + Options
3.6 quarters
Top 10 Avg Time Held Equity + Options
0.7 quarters
Top 20 Avg Time Held Equity + Options
0.8 quarters
Avg Time Held Equity only
3.7 quarters
Top 10 Avg Time Held Equity only
0.7 quarters
Top 20 Avg Time Held Equity only
0.8 quarters

Top Buys

Rank Stock Value
1
OSH
Oak Street Health, Inc.
OSH
+$211M
2
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
+$189M
3
UNVR
Univar Solutions Inc.
UNVR
+$175M
4
MAXR
Maxar Technologies Inc. Common Stock
MAXR
+$143M
5
AQUA
Evoqua Water Technologies Corp. Common Stock
AQUA
+$137M

Top Sells

Rank Stock Value
1
STOR
STORE Capital Corporation
STOR
+$414M
2
LHCG
LHC Group LLC
LHCG
+$211M
3
ATVI
Activision Blizzard
ATVI
+$196M
4
SGFY
Signify Health, Inc.
SGFY
+$161M
5
ONEM
1Life Healthcare
ONEM
+$141M

Sector Composition

Rank Sector Weight
1 Financials 22.21%
2 Healthcare 21.3%
3 Technology 18.64%
4 Miscellaneous 15.12%
5 Industrials 5.57%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow Held Since
HZNP
1
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
$434M 10.3%
3,992,732
+1,706,942
+75% +$189M
2022 Q1
4 quarters
ATVI
2
DELISTED
Activision Blizzard
ATVI
$256M 6.07%
2,993,503
-2,529,079
-46% -$196M
2022 Q1
4 quarters
UNVR
3
DELISTED
Univar Solutions Inc.
UNVR
$180M 4.28%
+5,150,743
New +$175M
2023 Q1
0 quarters
FHN icon
4
First Horizon
FHN
$10.9B
$179M 4.25%
10,082,989
+1,118,140
+12% +$24.8M
2022 Q1
4 quarters
AQUA
5
DELISTED
Evoqua Water Technologies Corp. Common Stock
AQUA
$146M 3.45%
+2,926,514
New +$137M
2023 Q1
0 quarters
VMW
6
DELISTED
VMware, Inc
VMW
$136M 3.23%
1,092,087
+103,188
+10% +$12.4M
2022 Q2
3 quarters
SGEN
7
DELISTED
Seagen Inc. Common Stock
SGEN
$116M 2.76%
576,429
+572,868
+16,087% +$91.9M
2022 Q3
2 quarters
ACI icon
8
Albertsons Companies
ACI
$5.92B
$104M 2.47%
+5,009,398
New +$103M
2023 Q1
0 quarters
TSEM icon
9
Tower Semiconductor
TSEM
$25.9B
$80.8M 1.92%
1,902,725
+189,190
+11% +$7.9M
2022 Q1
4 quarters
SIMO icon
10
Silicon Motion
SIMO
$8.95B
$76.4M 1.81%
1,166,615
+9,587
+0.8% +$629K
2022 Q2
3 quarters
FOCS
11
DELISTED
Focus Financial Partners Inc. Class A
FOCS
$71M 1.68%
+1,368,000
New +$65.9M
2023 Q1
0 quarters
PRVB
12
DELISTED
Provention Bio, Inc. Common Stock
PRVB
$70.5M 1.67%
+2,925,000
New +$36.7M
2023 Q1
0 quarters
OXY.WS icon
13
Occidental Petroleum Corp Warrants
OXY.WS
$35.8B
$53M 1.26%
1,300,000
+109,552
+9% +$4.43M
2021 Q1
8 quarters
XM
14
DELISTED
Qualtrics International Inc. Class A Common Stock
XM
$45.3M 1.07%
+2,541,707
New +$38.8M
2023 Q1
0 quarters
NATI
15
DELISTED
National Instruments Corp
NATI
$36.4M 0.86%
+694,762
New +$34.8M
2023 Q1
0 quarters
LQD icon
16
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
$27.6B
$30.7M 0.73%
+280,000
New +$30.3M
2023 Q1
0 quarters
CPAA
17
DELISTED
Conyers Park III Acquisition Corp. Class A Common Stock
CPAA
$29.7M 0.7%
2,932,368
– –
2021 Q4
5 quarters
AUY
18
DELISTED
Yamana Gold, Inc.
AUY
$29.4M 0.7%
+5,022,158
New +$28.6M
2023 Q1
0 quarters
AMYT
19
DELISTED
Amryt Pharma plc American Depositary Shares
AMYT
$29.2M 0.69%
2,000,000
– –
2020 Q4
9 quarters
SCRM icon
20
DELISTED
Screaming Eagle Acquisition Corp. Class A Ordinary Shares
SCRM
$25.9M 0.61%
2,548,547
– –
2022 Q1
4 quarters
OSH
21
DELISTED
Oak Street Health, Inc.
OSH
$25.3M 0.6%
+6,537,297
New +$211M
2023 Q1
0 quarters
RYAAY icon
22
Ryanair
RYAAY
$28.1B
$25M 0.59%
662,258
+5,990
+0.9% +$221K
2020 Q1
12 quarters
GHIX icon
23
DELISTED
Gores Holdings IX, Inc. Class A Common Stock
GHIX
$23.4M 0.55%
2,316,861
– –
2022 Q1
4 quarters
NPAB icon
24
DELISTED
New Providence Acquisition Corp. II Class A Common Stock
NPAB
$23.1M 0.55%
2,227,500
– –
2022 Q1
4 quarters
SAVE icon
25
DELISTED
Spirit Airlines, Inc.
SAVE
$21.5M 0.51%
+1,250,000
New +$23.4M
2023 Q1
0 quarters
1
2 3 4 5

Similar funds

FNBT
FineMark National Bank & Trust Fort Myers, Florida $3.2B AUM 18.28% 1-Year Est. Return
ACI
Alpha Cubed Investments Irvine, California $2.92B AUM 31.27% 1-Year Est. Return
RC
RGM Capital Naples, Florida $2.06B AUM 8.49% 1-Year Est. Return
A
AlphaQuest New York $1.79B AUM 10.61% 1-Year Est. Return
CGL
Clarius Group LLC Seattle, Washington $1.75B AUM 19.04% 1-Year Est. Return
CB
Cadence Bank Tupelo, Mississippi $1.71B AUM 16.17% 1-Year Est. Return
JCM
Janney Capital Management Pittsburgh, Pennsylvania $1.59B AUM 23.25% 1-Year Est. Return
MPM
Meritage Portfolio Management Overland Park, Kansas $1.51B AUM 26.61% 1-Year Est. Return

UBS O'Connor's Q1 2023 Portfolio in Review

As of Q1 2023, UBS O'Connor held 893 positions worth $4.22B, down 22% from $5.42B the previous quarter. Its ten largest holdings account for 41% of the portfolio.

UBS O'Connor withdrew a net $1.32B in Q1 2023, closing 273 positions and reducing 82 holdings. Its most notable exit was STORE Capital Corporation, an estimated $414M position sold in full.

By sector, the portfolio is most concentrated in Financials at 22% of assets, down from 26% a quarter earlier, followed by Healthcare and Technology.

Against the trend, UBS O'Connor opened a new position in Oak Street Health, Inc. worth $25.3M.

  • UBS O'Connor's largest Q1 2023 buy was Oak Street Health, Inc.: 6,537,297 shares worth $25.3M.
  • UBS O'Connor added most to Horizon Therapeutics Public Limited Company Ordinary Shares in Q1 2023, an estimated $189M increase.
  • UBS O'Connor's biggest Q1 2023 reduction was Activision Blizzard, cutting an estimated $196M.
  • UBS O'Connor fully exited STORE Capital Corporation in Q1 2023, selling an estimated $414M.
  • UBS O'Connor's ten largest holdings make up 41% of its $4.22B portfolio in Q1 2023.
  • UBS O'Connor opened 143 new positions and closed 273 in Q1 2023.
  • UBS O'Connor's portfolio value fell 22% quarter-over-quarter to $4.22B.

Based on UBS O'Connor's 13F filing for Q1 2023, filed 15 May 2023.